Gustav Hallén
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gustav Hallén has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Anton J. M. Larsson
Karolinska Institutet
1 shared publication - Christoph Ziegenhain
Division of Medical Systems Bioengineering, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
1 shared publication - Daniel Ramsköld
Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden
1 shared publication - Gert-Jan Hendriks
Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden
1 shared publication - Johan Hartman
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
1 shared publication - Leonard Hartmanis
Karolinska Institutet
1 shared publication
Latest Publications
- Open Access
- 18 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 6629
Deciphering direct transcriptional effects of epigenetic compounds through large-scale new RNA profiling
Examining direct transcriptional effects of genetic and chemical perturbations is crucial for understanding gene expression mechanisms. Standard RNA-seq experiments often overlook these direct effects, and current methods for profiling nascent RNA are usually time-consuming. Here, we adapted single-cell 4sU-based sequencing into a scalable, automated mini-bulk format to profile new RNA in smaller cell populations. This approach enabled us to map the direct transcriptional effects of epigenetic regulators. Brief exposure to SAHA (an HDAC inhibitor) revealed hundreds of directly responsive genes, many showing altered transcriptional bursting kinetics, with promoter regions enriched in binding sites for factors including bromodomain proteins. Profiling 83 epigenetic compounds uncovered direct transcriptional impacts from inhibitors of bromodomain proteins, histone deacetylases, and histone demethylases. Notably, chemically similar HDAC inhibitors elicited concordant direct responses and intronic expression analyses mirrored the direct effects seen in new RNA. This work highlights powerful approaches for investigating transcriptional mechanisms.
- 18 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 6629
Open AccessDeciphering direct transcriptional effects of epigenetic compounds through large-scale new RNA profiling
Examining direct transcriptional effects of genetic and chemical perturbations is crucial for understanding gene expression mechanisms. Standard RNA-seq experiments often overlook these direct effects, and current methods for profiling nascent RNA are usually time-consuming. Here, we adapted single-cell 4sU-based sequencing into a scalable, automated mini-bulk format to profile new RNA in smaller cell populations. This approach enabled us to map the direct transcriptional effects of epigenetic regulators. Brief exposure to SAHA (an HDAC inhibitor) revealed hundreds of directly responsive genes, many showing altered transcriptional bursting kinetics, with promoter regions enriched in binding sites for factors including bromodomain proteins. Profiling 83 epigenetic compounds uncovered direct transcriptional impacts from inhibitors of bromodomain proteins, histone deacetylases, and histone demethylases. Notably, chemically similar HDAC inhibitors elicited concordant direct responses and intronic expression analyses mirrored the direct effects seen in new RNA. This work highlights powerful approaches for investigating transcriptional mechanisms.